Ignite Creation Date:
2024-05-06 @ 10:16 AM
Last Modification Date:
2024-10-26 @ 12:27 PM
Study NCT ID:
NCT03205163
Status:
COMPLETED
Last Update Posted:
2022-04-19
First Post:
2017-06-29
Brief Title:
A Safety Tolerability and Pharmacokinetics Study of a Single Intravenous Injection of Recombinant Coagulation Factor VIII Fc - Von Willebrand Factor - XTEN Fusion Protein rFVIIIFc-VWF-XTEN BIVV001 in Previously Treated Adults With Severe Hemophilia A EXTEN-A
Sponsor:
Bioverativ a Sanofi company
Organization:
Sanofi
Organization Data
Organization:
Sanofi
Class:
INDUSTRY
Study ID:
TDU16220
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bioverativ a Sanofi company
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None